The cosmetics industry is growing, but by just how much? According to iData Research, a Vancouver-based pharmaceutical market research firm, the market for facial aesthetics, lasers and cosmetic surgery is expected to double—exceeding $3 billion by 2017.The U.S. market for facial injectables is currently worth almost $860 million. The expected introduction of new injectables—such as Mentor’s PurTox and Merz's Xeomin—as well as their increasing therapeutic uses will contribute to market growth.
“A growing number of doctors are looking at the therapeutic potential of botulinum A. There are more cosmetic procedures performed using botulinum A than therapeutic; however, therapeutic procedures use higher doses of the drug, therefore these two markets are similar in value,” says Kamran Zamanian, Ph.D., iData CEO.
The iData report predicts that the value of the botulinum toxin A market segment alone will reach $543 million within seven years. Cosmetic Surgery Times also cited laser skin resurfacing, hair removal and lipolysis as the fastest-growing market segments.
